Dr. rer. nat. Barbara Jentges

Barbara is a Senior Drug Regulatory Affairs Expert with more than 24 years of experience in the area of Drug Regulatory Affairs, in particular in the field of small molecule and biotech pharmaceutical products.

She has been lecturing at ETH (Swiss Federal Institute of Technology), Department of Chemistry and Applied Biosciences in Zurich, Switzerland, in the Master´s curriculum Medicinal and Industrial Pharmaceutical Sciences (MSc MIPS)  (from 2008 to 2022), at the FHNW (University of Applied Sciences and Arts North-western Switzerland), School of Life Sciences, Muttenz/Basel, Switzerland (2011 to 2022), at the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG) in Bern (since 2017) and at the Bern University of Applied Sciences  (since 2018).  She worked for a long time as an assessor of the Federal Institute for Drugs and Medical Devices (BfArM: Bundesinstitut für Arzneimittel und Medizinprodukte) in Germany.

Within the Parenteral Drug Association (PDA) Barbara was a member of PDAs Regulatory Affairs and Quality Advisory Board and served as the European co-chair of PDAs Regulatory Affairs Interest Group.

As an editor and co-author she recently published the second edition of a book titled regarding Pharmaceutical Legislation of the European Union, Japan and the United States of America – An Overview (Second Edition 2016) issued by the Parenteral Drug Association, Inc., Bethesda, MD 20815, US.

Barbara studied pharmacy at the University of Frankfurt/M.,Germany, and obtained a doctorate in pharmaceutical chemistry from the University of Tübingen/Germany in 1990.